Cresset® collaborates with global leaders Enamine to enable the design of exciting new Targeted Protein Degraders

Rho names renowned neurologist Andrew Feigin, MD, as Chief Medical Officer

Rho, a full-service contract research organization (CRO), has appointed leading neurologist Dr. Andrew Feigin as its new chief medical officer (CMO). In this pivotal global role, Dr. Feigin will provide strategic medical and operational expertise across multiple therapeutic areas, ensuring the integrity and safety of Rho’s clinical trials. Dr. Feigin's career is marked by groundbreaking contributions to neurology and clinical research. He served as the site principal investigator on more than 30 clinical trials, notably spearheading the first phase 1 clinical trial using gene therapy for Parkinson's disease. His prolific contributions to the field include over 150 peer-reviewed articles and numerous advisory board positions.

Indica Labs Announces Launch of AI-Powered Macrodissection Suite to Advance Molecular Pathology Workflows

Indica Labs has announced the launch of Lung Macrodissect AI, a groundbreaking tool that revolutionizes slide macrodissection and molecular pathology workflows.

New Survey Shows Strong Patient Support for Personalized Obesity Interventions

Respondents ages 18 to 65 highlight urgency for medical recognition, scientifically proven interventions, and genetic testing for personalized obesity treatment.

1upHealth Launches Customer Advisory Board to Advance Industry-Wide Interoperability and Fuel Technological Innovation

AVIA’s Generative AI Strategic Collaborative Enters Phase 2, Accelerating Healthcare AI Adoption and Real-World Applications

Sapio Sciences and Zifo Announce Strategic Partnership

Phreesia Now Available on Oracle Healthcare Marketplace

Phreesia is now available on Oracle Healthcare Marketplace and can be integrated with the Oracle Health Electronic Health Record (EHR).

Ansa Biotechnologies Pushes Limits of Complex DNA Synthesis with Launch of New Commercial Products

Ansa Biotechnologies announced the commercial availability of its Ansa Clonal DNA and Ansa DNA Fragments.

Clinion Wins The Clinical Trials Arena Excellence Award 2024 for Innovation

Clinion, a Lifescience technology company based out of the US, UK and India, has won a category award in the 2024 Clinical Trials Arena Excellence Awards in the Innovation category for its eClinical Platform.

Intelliguard Announces Shane Smith as Chief Strategy Officer

Intelliguard, a provider of data integration and RFID-enabled medication management solutions, named Shane Smith its Chief Strategy Officer.

Clearwater Managed Cloud Services Help Healthcare Organizations Leverage the Power of Microsoft Azure with Reduced Risk

Creative Biostructure Provides a Wide Range of Plant Exosomes to Enhance Skincare Research

Creative Enzymes Redefines Sustainability in Enzyme Innovation with Yeast-Fermented Vegan Collagen

Inizio Engage and Nye Health form a strategic alliance to enhance patient support and outcomes

Creative Enzymes Unveils Semaglutide, a Promising Solution for Comprehensive Diabetes Management

AI for Good: Insilico Medicine Hosts IMGAIA Product Launch Event

Insilico Announces Sustainability Benchmarking Initiative and New Gen-AI Features of Pharma.AI Platform

Peerbridge Health Launches EF-ACT Pivotal Trial to Determine Ejection Fraction Severity from AI-Enabled Remote ECG Wearable

Peerbridge Health Launches EF-ACT Pivotal Trial to Determine Ejection Fraction Severity from AI-Enabled Remote ECG Wearable

Thymmune Therapeutics Announces Manish Jain as CTO

Biotech company developing thymic cell engineering platform bolsters leadership team with veteran biopharmaceutical hire.

Cresset integrates Spark™ in latest release of Flare™ - from novel idea generation to extensive optimization

Drug discovery specialists Cresset have launched the latest version of their drug discovery platform Flare, which aims to unleash the potential of creative molecule design in the early drug discovery process.